Understanding the Immunological Consequences Of

Understanding the Immunological Consequences Of

IFD-KIL:KLI<KF LE:K@FEKF*8K?F><E<J@J/E;<IJK8E;@E>K?<#DDLEFCF>@:8CFEJ<HL<E:<J F=.?</E@HL<*<GK@;F>CP:8EF= '8I@J<C8' 8M@J .?<J@JJL9D@KK<;KFK?<=8:LCKPF=K?<0@I>@E@8*FCPK<:?E@:#EJK@KLK<8E;-K8K</E@M<IJ@KP@E G8IK@8C=LC=@CCD<EKF=K?<I<HL@I<D<EKJ=FIK?<;<>I<<F= '8JK<IF=-:@<E:< #E &@=<-:@<E:<J I8E;FE& $LKI8J:?8@I 8IFC@E<( $FE<J 4?@A@8E$8B<.L '8PK? C8:BJ9LI>0@I>@E@8 %<PNFI;J&PD<;@J<8J<G<GK@;F>CP:8E@EE8K< 8;8GK@M<@DDLE@KP FGPI@>?K '8I@J<C8' 8M@J IFD-KIL:KLI<KF LE:K@FEKF*8K?F><E<J@J/E;<IJK8E;@E>K?<#DDLEFCF>@:8CFEJ<HL<E:<J F=.?</E@HL<*<GK@;F>CP:8EF= '8I@J<C8' 8M@J !'-)16-*-'&564%'6 .?< 98:K<I@8C G8K?F><E I<JGFEJ@9C< =FI &PD< ;@J<8J< T " @J 8E 8KPG@:8C!I8D E<>8K@M<JG@IF:?<K<K?8K@JKI8EJD@KK<;KF?LD8EJM@8K?<9@K<F=8E@E=<:K<; K@:B &@B< 8CC !I8D E<>8K@M< 98:K<I@8 K?< JKIL:KLI8C GFIK@FE F= K?< :<CC <EM<CFG< BEFNE 8J G<GK@;F>CP:8E*!@JJ8E;N@:?<;9<KN<<EK?<@EE<I8E;FLK<ID<D9I8E<J /EC@B<M@IKL8CCP8CC 98:K<I@8K?@J*!C8P<I@JLE@HL<@E@EK?8KK?<8D@EF8:@;JKIL:KLI<;@==<IJ=IFDDFJK !I8D E<>8K@M<8E;!I8D GFJ@K@M<98:K<I@89PK?<8;;@K@FEF=8E)IE@K?@E<I<J@;L<KFK?<K?@I; 8D@EF 8:@; CF:8K@FE @E K?< :IFJJC@EB@E> JKIL:KLI< .?@J LE@HL< DFK@= @J ?PGFK?<J@Q<; KF 9< I<JGFEJ@9C< =FI K?< LELJL8C :C@E@:8C D8E@=<JK8K@FEJ J<<E @E &PD< ;@J<8J< JG<:@=@:8CCP &PD< 8IK?I@K@JK?<DFJK:FDDFEC8K<JK8><JPDGKFDF=K?<;@J<8J<@EK?</E@K<;-K8K<J *<GK@;F>CP:8E @JFECPFE<:FDGFE<EKF=K?<:<CC<EM<CFG<@EK?FL>?FK?<IGFIK@FEJF=K?<:<CC <EM<CFG<I<D8@ELE;<IJKL;@<;JG<:@=@:8CCPN?<EM@<N<;K?IFL>?K?<C<EJF=K?<@DDLE<I<JGFEJ< K?<P D8P <C@:@K @E 8;;@K@FE KF K?8K F= *! .?< :FD9@E<; @DDLEFCF>@:8C <==<:K F= K?< LE@HL< 98:K<I@8C 8EK@><E =FLE; @E *! 8J N<CC 8J FK?<I GFK<EK@8CCP 8JJF:@8K<; GIFK<@EJ :FEK8@E<;N@K?@EK?<:<CCN8CC8I<<OGCFI<;?<I< .?<J<JKL;@<J=LIK?<IFLILE;<IJK8E;@E>F=K?< :<CC<EM<CFG<8E;GIFM@;<:I@K@:8C@E=FID8K@FEK?8KLE;<IC@<JK?<<CLJ@M<G8K?F><E<J@J F=&PD<;@J<8J< IFD-KIL:KLI<KF LE:K@FEKF*8K?F><E<J@J/E;<IJK8E;@E>K?<#DDLEFCF>@:8CFEJ<HL<E:<J F=.?</E@HL<*<GK@;F>CP:8EF= '8I@J<C8' 8M@J )1)4%/7(-)1')&564%'6 &PD< ;@J<8J< @J 8 >IFN@E> ?<8CK? :FE:<IE E8D<CP =FI K?< :FLEKI@<J @E K?< (FIK?<IE "<D@JG?<I< .?<98:K<I@LDI<JGFEJ@9C<=FIK?@J@CCE<JJ@J:8E JLIM@M<@EK?<?LD8E9F;P8E;@J8K?I<8K@EK?8K8J@KI<GC@:8K<J@EK?<?LD8E?FJK@KJ?<;JGIF @E=C8DD8KFIP=I8>D<EKJF=@KJLE@HL<:<CCN8CC@EKFK?<<EM@IFED<EK .?@JK?<J@JN@CC<OGCFI<K?< :FEJ<HL<E:<JF=K?@J:<CCN8CCJ?<;;@E>8E;?FNK?<?LD8E@DDLE<I<JGFEJ<;@==<IJ=IFDK?< I<JGFEJ<J<<E@EFK?<IDFI<:FDDFE98:K<I@8 ;;@K@FE8CCP#?8M<=FLE;K?8KK?<:<CC<EM<CFG< =I8>D<EKJJ?<;=IFDD8P:FEK8@EDFI<K?8ED<<KJK?<<P< .?<I<@J<M@;<E:<?<I< KFJLGGFIKK?<;@J:FM<IPF=8DFFEC@>?K@E>GIFK<@EK?8K@J9FLE;KF8GFIK@FEF=K?<:<CCN8CC@E .?@JGIFK<@E8:KJKF9FCJK<IK?<JKIL:KLI8C@EK<>I@KPF=K?<:<CCN?@C<8CJF8:K@E>KF DF;LC8K<K?<?FJK@DDLE<I<JGFEJ< '.129/)(+)0)165 U.ILJK@EK?<&FI;N@K?8CCPFLI?<8IK8E;C<8EEFKFEPFLIFNELE;<IJK8E;@E> #E8CCPFLIN8PJ8:BEFNC<;><"@D8E;"<J?8CCD8B<PFLIG8K?JKI8@>?K V *IFM<I9J ?8E;C<I'FD8;'@>J8E;'<C@E8K?8EBPFL=FICFM@E>D<JLGGFIK@E>D<8E;GI8P@E> =FID< 3FL8CC8I<DPJLGGFIKJPJK<D8E;#NFLC;EXK9<?<I<N@K?FLKP8XCC 8M@;&8CCPK?8EBPFL=FI9<C@<M@E>@ED<8E;FG<E@E>LG;FFIJ=FID<KFN8CBK?IFL>?PFL ?<CG<;D<=@E;FGGFIKLE@K@<JKFJL::<<;@E8E;#8D=FI<M<IK?8EB=LC=FIK?8K I $LKI8JPFLK8L>?KD<<M<IPK?@E>BEFN89FLK9<@E>8J:@<EK@JK8!))J:@<EK@JK .?8EBPFL =FIK8B@E>D<@EK<8:?@E>D<>L@;@E>D<8E;JK8E;@E>N@K?D<K?IFL>?FLKK?@JAFLIE<P #8D =FI<M<I>I8K<=LCKFPFL8E;K?<=8D@CPK?8K#?8M<D8;<N?@C<@EK?<$LKI8JC89 )EN8I; @M Table of Contents Acknowledgements ......................................................................................................................... iv List of Figures ................................................................................................................................ vi List of Tables ................................................................................................................................. vii List of Abbreviations .................................................................................................................... viii CHAPTER 1 .................................................................................................................................... 1 Literature Review ............................................................................................................................ 1 Lyme Disease Epidemiology ........................................................................................................... 1 The Enzootic Cycle of Borrelia burgdorferi ................................................................................... 2 Borrelia burgdorferi Physiology ..................................................................................................... 3 Lyme Disease Pathogenesis ............................................................................................................ 5 The innate immune response to Borrelia burgdorferi .................................................................... 6 The adaptive immune response to Borrelia burgdorferi ............................................................... 10 Borrelia burgdorferi evasion and dissemination .......................................................................... 11 References ..................................................................................................................................... 14 CHAPTER II ................................................................................................................................. 22 Insights in the Characterization of the Immune Response to B. burgdorferi Peptidoglycan ....... 22 Introduction ................................................................................................................................... 22 Methodology ................................................................................................................................. 23 Results ........................................................................................................................................... 27 Discussion ..................................................................................................................................... 32 References ..................................................................................................................................... 67 CHAPTER III ................................................................................................................................ 71 NapA is a Peptidoglycan Associating Protein in B. burgdorferi .................................................. 71 Introduction ................................................................................................................................... 71 Methodology ................................................................................................................................. 72 Results ........................................................................................................................................... 80 Discussion ..................................................................................................................................... 88 References ................................................................................................................................... 108 CHAPTER IV .............................................................................................................................. 114 Conclusions and Future Directions ............................................................................................ 114 References ................................................................................................................................... 118 M -562*-+74)5 @>LI< *!JKIL:KLI<8E;;@==<I<EK@8K@FE @>LI<FOGI<JJJ@FEE8CPJ@J @>LI<!)EI@:?D<EKE8CPJ@J,<JLCKJ=FIK?<*'J-K@DLC8K<;N@K?8:K<I@8C*!J=FI 8E;"FLIJ @>LI<!<E<OGI<JJ@FEE8CPJ@J@E*'J-K@DLC8K<;N@K?8:K<I@8C*!J=FI 8E; "FLIJ @>LI<%!!EI@:?D<EKE8CPJ@J,<JLCKJ=FIK?<*'J-K@DLC8K<;N@K?8:K<I@8C*!J=FI 8E;"FLIJ @>LI<CLJK<IE8CPJ@JF=@==<I<EK@8CCPOGI<JJ<;!<E<J @>LI<!)EI@:?D<EKE8CPJ@J,<JLCKJ=FIK?<*'J-K@DLC8K<;N@K?*!9FI&@M< 8K :<CCJ D&=FI 8E;?FLIJ @>LI<%!!EI@:?D<EKE8CPJ@J,<JLCKJ=FIK?<*'JJK@DLC8K<;N@K?*!9FI&@M< 8K :<CCJ D&=FI 8E;"FLIJ @>LI<!<E<OGI<JJ@FEE8CPJ@J@E*'J-K@DLC8K<;N@K?8:K<I@8C*!J=FI 8E; "FLIJ @>LI< !<E<OGI<JJ@FEE8CPJ@J@E*'J-K@DLC8K<;N@K?&@M<8K :<CCJ D&=FI 8E;"FLIJ @>LI< #;<EK@=@:8K@FEF=G<GK@;F>CP:8E 8JJF:@8K<;GIFK<@EJ**J@E @>LI< (8G@J8** @>LI< &PJFQPD<8E;(8CJKI<JJK<JKJ @>LI< <CC<EM<CFG<JKI<JJ8E;;<=<:KJF=(8G;<=@:@<EK98:K<I@8 @>LI< (8G *!@JI<C<8J<;@EFLK<I D<D9I8E<M<J@:C<J8E;KF><K?<I8:K8J8E<LKIFG?@C :?<DF8KKI8:K8EK @>LI< *?PCF><E<K@:E8CPJ@JF=(8G M@ -562*"%&/)5 .89C< ,(-<HL<E:@E>-8DGC<(8D<J .89C< @==<I<EK@8CCPOGI<JJ<;!<E<JF=#EK<I<JK@E*'J-K@DLC8K<;N@K?*!9=FI "FLIJ .89C< @==<I<EK@8CCPOGI<JJ<;!<E<JF=#EK<I<JK@E*'J-K@DLC8K<;N@K?*!9=FI ?FLIJ .89C< @==<I<EK@8CCPOGI<JJ<;!<E<JF=#EK<I<JK@E*'J-K@DLC8K<;N@K?&@M< =FI "FLIJ .89C< @==<I<EK@8CCPOGI<JJ<;!<E<JF=#EK<I<JK@E*'J-K@DLC8K<;N@K?&@M< =FI"FLIJ .89C< ,<8:KFD<E8CPJ@J*FJK "FLI*'-K@DLC8K@FEN@K?*!-D .89C< ,<8:KFD<E8CPJ@J*FJK "FLI*'-K@DLC8K@FEN@K?*!-8 .89C< ,<8:KFD<E8CPJ@J*FJK "FLI*'-K@DLC8K@FEN@K?*!: .89C< ,<8:KFD<E8CPJ@J*FJK "FLI*'-K@DLC8K@FEN@K?*!J .89C< ,<8:KFD<E8CPJ@J*FJK "FLI*'-K@DLC8K@FEN@K?*!9 .89C< !)E8CPJ@J!I8ELCF:PK<:K@M8K@FE*8K?N8P .89C< !)E8CPJ@J!I8ELCF:PK<:K@M8K@FE*8K?N8P .89C< ,<8:KFD<E8CPJ@J*FJK "FLI*'-K@DLC8K@FEN@K?&@M< .89C< ,<8:KFD<E8CPJ@J*FJK"FLI*'-K@DLC8K@FEN@K?&@M< .89C< )EI@:?D<EKE8CPJ@J .89C< -LDD8IP& '-I<JLCKJ=IFD**J:I<<E .89C< *8I<EK8C:CFE< DLK8K@FEJI<C8K@M<KF

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    126 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us